Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Revance Therapeutics Inc.
Goto 0, 1, 2, ...4, 5, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-13
Purchase
2021-12-15
8:17 pm
Revance Therapeutics Inc. RVNC Russell Angus C.
Director
6,400 $15.74 $100,741 26,913
(Direct)
View
2021-12-03
Purchase
2021-12-06
8:34 pm
Revance Therapeutics Inc. RVNC Rankin Aubrey
President Innovation & Tech
30,000 $14.43 $432,876 571,376
(Indirect
Direct)
View
2021-11-29
Purchase
2021-11-29
9:24 pm
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
40,000 $12.9 $515,924 879,978
(Indirect
Direct)
View
2021-09-27
Sale
2021-09-28
9:23 pm
Revance Therapeutics Inc. RVNC Moxie Dwight
VP
1,675 $30 $50,250 47,804
(Direct)
View
2021-08-15
Sale
2021-08-17
6:20 pm
Revance Therapeutics Inc. RVNC Rankin Aubrey
President Innovation & Tech
9,364 $26.34 $246,659 541,376
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-30
Option Award
2022-07-05
6:15 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
1,000 $11.75 877,674
(Direct)
View
2022-06-30
Option Award
2022-07-05
6:15 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
President
1,000 $11.75 98,123
(Direct)
View
2022-06-30
Option Award
2022-07-05
6:15 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
965 $11.75 63,490
(Direct)
View
2022-05-04(A)
Option Award
2022-05-13
6:17 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Russell Angus C.
Director
10,756 $0 10,756
(Direct)
View
2022-05-04(A)
Option Award
2022-05-13
6:16 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Ware Olivia C
Director
10,756 $0 10,756
(Direct)
View
2022-05-04(A)
Option Award
2022-05-13
6:14 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Gangolli Julian S
Director
10,756 $0 10,756
(Direct)
View
2022-05-04(A)
Option Award
2022-05-13
6:13 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Vickers Philip J.
Director
10,756 $0 10,756
(Direct)
View
2022-05-04(A)
Option Award
2022-05-13
6:11 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Nolet Chris
Director
10,756 $0 10,756
(Direct)
View
2022-05-04(A)
Option Award
2022-05-13
6:10 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Kolaja Carey OConnor
Director
10,756 $0 10,756
(Direct)
View
2022-05-04(A)
Option Award
2022-05-13
6:08 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Beraud Jill
Director
10,756 $0 10,756
(Direct)
View
2022-05-04
Option Award
2022-05-06
6:20 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Vickers Philip J.
Director
17,402 $0 41,065
(Direct)
View
2022-05-04
Option Award
2022-05-06
6:19 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Nolet Chris
Director
17,402 $0 36,415
(Direct)
View
2022-05-04
Option Award
2022-05-06
6:19 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Kolaja Carey OConnor
Director
17,402 $0 24,370
(Direct)
View
2022-05-04
Option Award
2022-05-06
6:18 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Gangolli Julian S
Director
17,402 $0 37,915
(Direct)
View
2022-05-04
Option Award
2022-05-06
6:18 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Beraud Jill
Director
17,402 $0 36,415
(Direct)
View
2022-05-04
Option Award
2022-05-06
6:18 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Russell Angus C.
Director
17,402 $0 44,315
(Direct)
View
2022-05-04
Option Award
2022-05-06
6:17 pm
N/A
2032-05-03
Revance Therapeutics Inc. RVNC Ware Olivia C
Director
17,402 $0 24,484
(Direct)
View
2022-03-15
Tax Withholding
2022-03-17
5:56 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
2,607 $15.79 120,708
(Direct)
View
2022-03-15
Tax Withholding
2022-03-17
5:54 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
3,304 $15.79 876,674
(Direct)
View
2022-03-15
Tax Withholding
2022-03-17
5:52 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Moxie Dwight
VP
5,110 $15.79 42,694
(Direct)
View
2022-03-15
Tax Withholding
2022-03-17
5:50 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Rankin Aubrey
Director
1,372 $15.79 570,004
(Direct)
View
2022-03-15
Tax Withholding
2022-03-17
5:48 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
2,607 $15.79 62,525
(Direct)
View
2022-03-15
Tax Withholding
2022-03-17
5:43 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
President
1,835 $15.79 97,123
(Direct)
View
2022-02-15
Tax Withholding
2022-02-17
8:54 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
President
2,429 $13.35 98,958
(Direct)
View
2022-02-15
Tax Withholding
2022-02-17
8:51 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Joshi Abhay
COO
5,053 $13.35 123,315
(Direct)
View
2022-02-15
Tax Withholding
2022-02-17
8:49 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
2,924 $13.35 65,132
(Direct)
View
2022-02-02
Option Award
2022-02-04
8:38 pm
N/A
2032-02-01
Revance Therapeutics Inc. RVNC Sjuts Dustin S
President
57,016 $0 57,016
(Direct)
View
2022-02-02
Option Award
2022-02-04
8:36 pm
N/A
2032-02-01
Revance Therapeutics Inc. RVNC Moxie Dwight
VP
68,093 $0 68,093
(Direct)
View
2022-02-02
Option Award
2022-02-04
8:35 pm
N/A
2032-02-01
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
143,354 $0 143,354
(Direct)
View
2022-02-02
Option Award
2022-02-04
8:31 pm
N/A
2032-02-01
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
68,093 $0 68,093
(Direct)
View
2021-12-31
Other
2022-01-04
8:58 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
404 $13.87 68,460
(Direct)
View
2021-12-15
Tax Withholding
2021-12-17
5:31 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Schilke Tobin
CFO
1,556 $15.92 67,652
(Direct)
View
2021-12-15
Tax Withholding
2021-12-17
5:29 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
President
513 $15.92 101,387
(Direct)
View
2021-11-09
Option Award
2021-11-10
8:32 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Sjuts Dustin S
President
35,920 $0 101,900
(Direct)
View
2021-10-13
Tax Withholding
2021-10-15
8:00 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Foley Mark J
CEO
42,096 $23.08 839,978
(Direct)
View
2021-08-15
Tax Withholding
2021-08-17
6:20 pm
N/A
N/A
Revance Therapeutics Inc. RVNC Rankin Aubrey
President Innovation & Tech
4,949 $26.02 541,376
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, ...4, 5, Next